Acelyrin Inc (SLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SLRN | SGMT | QTTB | ||
| Company | Acelyrin Inc | Sagimet Biosciences Inc Series A | Q32 Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.24 | 6.85 | 12.00 | ||
| High | 2.36 | 7.15 | 13.18 | ||
| Low | 2.20 | 6.80 | 11.99 | ||
| Latest | 2.27 | 7.06 | 13.17 | ||
| Change | +0.04 | +0.20 | +1.22 | ||
| % Change | +1.79% | +2.92% | +10.21% | ||
| Volume | 4,076,500 | 8,602,400 | 493,900 | ||
| 20-Day Average Volume | 1,091,300 | 1,335,015 | 573,835 | ||
| Previous Close | 2.23 | 6.86 | 11.95 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.33 | 6.77 | 12.40 | ||
| 20-Day Raw Stochastic | 45.16% | 70.09% | 62.67% | ||
| 20-Day Relative Strength | 47.29 | 53.80 | 61.19 | ||
| Weighted Alpha | -28.45 | -16.47 | +101.18 | ||
| Today's Opinion | 88% Sell | 56% Buy | 100% Buy | ||
| Previous Opinion | 88% Sell | 40% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Sell | 40% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.61% since 05/13/25 | +5.69% since 06/18/26 | +10.67% since 06/18/26 | ||
| Low | 1.95 on 05/15/25 | 6.68 on 06/22/26 | 10.55 on 06/25/26 | ||
| High | 2.36 on 05/20/25 | 7.34 on 06/23/26 | 13.39 on 06/22/26 | ||
| 1-Month | |||||
| %Chg | +3.18% since 04/17/25 | -2.22% since 05/26/26 | +85.75% since 05/26/26 | ||
| Low | 1.95 on 05/15/25 | 6.24 on 06/16/26 | 9.15 on 05/27/26 | ||
| High | 2.65 on 05/01/25 | 7.58 on 05/28/26 | 14.85 on 06/04/26 | ||
| 3-Month | |||||
| %Chg | +4.61% since 02/20/25 | +38.16% since 03/26/26 | +84.45% since 03/26/26 | ||
| Low | 1.95 on 05/15/25 | 4.50 on 03/30/26 | 4.77 on 04/27/26 | ||
| High | 2.94 on 04/02/25 | 9.37 on 04/27/26 | 14.85 on 06/04/26 | ||
| 6-Month | |||||
| %Chg | -48.76% since 11/20/24 | +18.46% since 12/26/25 | +311.56% since 12/26/25 | ||
| Low | 1.85 on 02/11/25 | 4.50 on 03/30/26 | 3.08 on 12/30/25 | ||
| High | 5.03 on 11/25/24 | 9.37 on 04/27/26 | 14.85 on 06/04/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 229,166 | 230,050 | 223,310 | ||
| Shares Outstanding, K | 100,954 | 32,585 | 16,956 | ||
| Annual Sales | 0 | 0 | 53,740,000 | ||
| Annual Net Income | -248,230,000 | -51,040,000 | 29,820,000 | ||
| Last Quarter Sales | 0 | 0 | 53,740,000 | ||
| Last Quarter Net Income | -55,260,000 | -10,650,000 | 57,730,000 | ||
| 60-Month Beta | 1.07 | 3.41 | 0.27 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 05/14/25 | -0.33 on 05/12/26 | -0.54 on 05/05/26 | ||
| Earnings Date | 08/12/25 | 08/12/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.91 | ||